Article Details

Ikena Oncology Announces Dosing of First Patient in Phase 1 Study Evaluating IK-175 in Patients ...

Retrieved on: 2020-01-27 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

Ikena Oncology Announces Dosing of First Patient in Phase 1 Study Evaluating IK-175 in Patients .... View article details on hiswai:

Excerpt

<div>Ikena has raised capital from top tier investors OrbiMed Advisors and <b>Atlas</b> <b>Venture</b>. For more information, visit www.ikenaoncology.com, or follow us ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up